Haemoglobinopathies are a group of hereditary diseases that result as a consequence of defect(s) in the genes responsible for the synthesis of haemoglobin. Depending on the molecular defect, haemoglobinopathies may be classified as either thalassaemias or structural hemoglobin variants.
Consequently a robust haemoglobinopathy screening method needs to be able to:
Our available haemoglobinopathy instrumentation is detailed below, which ultilises the principles of Ion Exchange Chromatography to give the very best separation possible.
You can also read more about variant haemoglobins here.
Ultra 2™ Variant
The Ultra2™ Variant incorporates a 4 minute Quick Scan program and a 10.5 minute High Resolution program for unattended screening and confirmation of haemoglobin variants.